Robert Hofmeister Tcr2 Therapeutics Inc. (TCRR) insider trading activity

Robert Hofmeister is Chief Scientific Officer of TCR2 THERAPEUTICS INC.. Currently has a direct ownership of 45,850 shares of TCRR, which is worth approximately $0. The most recent transaction as insider was on Dec 22, 2020, when has been sold 7,000 shares (Common Stock) at a price of $0.74 per share, resulting in proceeds of $5,180. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.9K

0% 3M change

0% 12M change

Total Value Held $0

Robert Hofmeister Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 22 2020	BUY Exercise of conversion of derivative security	$5,180 $0.74 p/Share	7,000 Added 13.25%	45,850 Common Stock
Nov 12 2020	SELL Open market or private sale	$502,000 $25.1 p/Share	20,000 Reduced 33.98%	38,850 Common Stock
Nov 12 2020	BUY Exercise of conversion of derivative security	$14,800 $0.74 p/Share	20,000 Added 29.05%	48,852 Common Stock
Oct 29 2020	SELL Open market or private sale	$382,000 $19.1 p/Share	20,000 Reduced 33.98%	38,850 Common Stock
Oct 29 2020	BUY Exercise of conversion of derivative security	$14,800 $0.74 p/Share	20,000 Added 25.36%	58,850 Common Stock

Also insider at

TCRT

Alaunos Therapeutics, Inc. Healthcare